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Background: Reduced osmolarity oral rehydration solution absorption (P< 0.001) as did reduced osmolarity ORS
(ORS) improved small bowel absorption of fluid and
electrolytes in segmental perfusion in experimental animals;
this was borne out in clinical practice. Adding amylase-resistant
starch (RS) to ORS is expected to increase colonic fluid
absorption. This study used combined small and large bowel
perfusion to evaluate combinations of reduced osmolarity and
starch in ORS.
Methods: Single-pass steady-state perfusions of the whole gut
at 30 mL/h, using the nonabsorbable marker 14C-polyethylene
glycol 4000, were performed in Wistar rats after exposure to
cholera toxin or Escherichia coli heat-stable enterotoxin (STa).
Results: Steady state was established within 90 minutes after
commencing perfusion. Net secretion of water, sodium and
chloride induced by cholera toxin was partially reversed by
standard glucose-ORS (G-ORS). Substituting glucose in
G-ORS with RS (RS-ORS) substantially increased net waterincott Williams & Wilkins.Unauth
006; accepted May 3, 2006.
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568(RO-ORS) (P< 0.001); addition of RS to RO-ORS further
increased water absorption (P< 0.001). In STa-treated
intestine, RO-ORS and RS-ORS significantly improved water
absorption compared to G-ORS (P< 0.005). RO- and RS-RO-
ORS did not significantly augment net electrolyte absorption
compared with G-ORS. RS-ORS was associated with highest
net absorption of sodium and chloride compared with all other
groups.
Conclusions: RS increased net water (and sodium) absorption
from isosmolar and reduced osmolar ORS consistent with
increased absorption by the colon. RS in reduced osmolar
ORS may have advantages to reduce severity of diarrhea and
prevent hyponatremia in severe diarrhea and may be applica-
ble to diarrhea of different etiologies. JPGN 43:568–575, 2006.
Key Words: Oral rehydration therapy—Diarrhea—Cholera—
Dehydration—Starch. # 2006 Lippincott Williams & WilkinsOral rehydration solution (ORS) is a well-established well as to increase small intestinal fluid and electrolyte
treatment for acute diarrhea by virtue of its stimulation of
fluid and electrolyte absorption in the small intestine. The
physiological basis for ORS is that glucose-stimulated
sodium absorption is not altered by cyclic adenosine
monophosphate (cAMP), while cAMP stimulates active
chloride secretion and inhibits electroneutral Na-Cl
absorption (1). Despite the substantial benefit provided
by ORS to correct dehydration and metabolic acidosis in
children with acute diarrhea, ORS does not substantially
reduce stool output (2). As a consequence, there have been
many attempts to modify ORS to reduce stool output asabsorption (3). Until recently, all of these approaches
focused on ORS modifications that would enhance small
intestinal fluid absorption. For example, different amino
acids have been used without substantial benefit (3). The
use of food polymers, which result in glucose production in
the proximal small intestine following pancreatic hydroly-
sis, has been effective. Thus, rice-based ORS was more
effective in the treatment of acute diarrhea than WHO
(World Health Organization)-ORS, although this benefit
appears to be confined to cholera (4). The identification of
an optimal ORS formulation has been facilitated by paral-
lel studies in experimental animals, usually rats, in which
segments of isolated portions or all of the small intestine
have been perfused with 1 solutions (5–7).
A different approach to improve ORS was recently
demonstrated that involved enhancement of colonic fluid
and electrolyte absorption (8) by the addition of starchorized reproduction of this article is prohibited.
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FIG. 1. Mean (SEM) recovery of PEG-4000 from rectal effluent,
expressed as percentage of PEG infused into the gut during that
same time, in each 30-min time period. PEG recovery reached
100% of the amount infused in the 30-min period from 60–90 min
after onset of perfusion, and remained at 95%–110% thereafter,
indicating steady-state conditions.
EVALUATION OF ORAL REHYDRATION SOLUTION 569that is relatively resistant to amylase digestion (resistant
starch, or RS). The use of RS-ORS was based on the
demonstration that stimulation of active Na-Cl absorp-
tion by short-chain fatty acids (SCFA) in the rat distal
colon was not inhibited by cAMP (9,10). It was proposed
that RS-ORS would result in an increase in the delivery of
nonabsorbed carbohydrate to the colon, where they
would be metabolized by colonic bacteria to SCFA
(11). Indeed, a clinical trial demonstrated that RS-ORS
was better than both WHO-ORS and rice flour (RF) ORS
in the treatment of acute cholera in adults (12).
Other studies had demonstrated that hypoosmolar ORS
was better than WHO-ORS (13–16). As a result, hypoos-
molar or reduced osmolar ORS was established as the
preferred ORS by the World Health Organization despite
concerns of the potential development of hyponatremia
in some patients with acute cholera (17–19). A critical
issue is to determine whether RS would also enhance the
treatment of acute diarrhea in patients treated with
reduced osmolar ORS because it had been shown to
do with WHO-ORS. However, the formulation of an
optimal RS-reduced osmolar ORS would require prior
perfusion studies in experimental animals. Because the
presumed site of absorption for RS is the colon and that
for reduced osmolar ORS is the small intestine, it would
be necessary first to establish a model in which both the
small and large intestines could be perfused together with
different modifications of ORS.
The present study was designed to develop a whole-gut
perfusion model in rats to identify the optimal formu-
lation of an RS-containing reduced osmolar ORS. In
these studies, different formulations of ORS that varied
the composition of RS and reduced osmolarity (RO) were
studied in rats exposed to either cholera toxin (CT) or the
heat-stable enterotoxin of Escherichia coli (STa).
METHODS
Adult Wistar albino rats (180–220 g body weight) used in all
experiments were fasted for 16 h with free access to water.
These experiments were approved by the Animal Ethics Com-
mittee of the Christian Medical College, Vellore. The rats were
anesthetized with intraperitoneal injection of sodium pentobar-
bitone (30 mg/kg body weight). Anesthesia was maintained
throughout the experiment by interval intraperitoneal injection
(10–15 mg/kg), as required. The abdomen was opened through
a midline incision, and the first part of the duodenum was
cannulated. The cecum was excluded by a ligature, taking care
to avoid ischemia. The colon was cleared of luminal feces and a
catheter placed in the rectum and secured by a ligature, taking
care not to compromise the blood supply. The intestine was
returned to the abdominal cavity and the abdomen closed.
Single-pass continuous perfusion of the whole gut was per-
formed at a rate of 30 mL/h using a syringe infusion pump
(Vickers). The tubing containing the infused solutions passed
through a water bath to maintain the temperature at 378C. Thet © 2006 by Lippincott Williams & Wilkins.Unaubody temperature of the animal was maintained at 378 0.58C
using an overhead lamp.
In these experiments, net fluid movement was determined by
changes in the concentration of polyethylene glycol of average
molecular weight 4000 (PEG-4000), a nonabsorbable marker,
which was added to all perfusion solutions together with 14C-
PEG. PEG concentration was determined by measuring 14C-
PEG in a liquid scintillation counter. Preliminary experiments
were designed to determine the time required to establish
steady-state conditions in both control animals and those in
whom fluid secretion had been induced by CT. In these exper-
iments, a Ringer solution (Na 140, K 5.2, Cl 119.8, HCO3 25,
H2PO4 0.4, HPO4 2.4, Mg 1.2, Ca 1.2, glucose 10 mmol/L) was
used as the perfusate. Rectal effluent was collected from the
beginning of perfusion at 15-minute intervals for a total of
5 hours and 14C-PEG activity was measured (Fig. 1). Steady-
state conditions were established between 60 and 90 minutes of
perfusion, as assessed by total 14C-PEG recovery and/or by
constant concentrations of 14C-PEG in the rectal effluent. The
meanSEM recovery of PEG for 30-minute periods over
300 minutes as the percentage of recovery of the amount infused
into the intestine during the corresponding period is shown in
Fig. 1. Similar results were observed in the animals that were
not exposed to CT (results not shown). As a result of these
observations, an equilibration period of 90 minutes was used
followed by 15-minute collection periods of effluent fluid in
subsequent experiments. Net water and electrolyte movement
was calculated from the 2 final collection periods. At the end of
the experiment, rats were killed by an overdose of anesthesia,
the abdomen was opened, and the perfused segment of bowel
was removed, opened out and stretched out on paper. The total
length of perfused bowel was measured. Each rat was perfused
with 1 solution. Results were expressed as microliters per
minute per centimeter or micromoles per minute per centimeter
of perfused intestine.
Studies with CT
In studies with CT (C-3015, Sigma Chemical, St Louis, MO)
100mg of CT added to 8 mL 0.9% NaCl was instilled into the
intestine, evenly dispersed by gentle squeezing of the intestinethorized reproduction of this article is prohibited.
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570 SUBRAMANYA ET AL.and then left in situ for 2 hours. Control studies were done
similarly by exposing the intestine to 8 mL 0.9% NaCl for 2
hours, after which perfusion studies were commenced.
Studies with STa
In experiments with STa (E-5763, Sigma Chemical), the
intestine was perfused with the test ORS for 90 minutes
to establish steady state, after which the same test
ORS containing 300mg/L STa was perfused for another 90
minutes. The concentration of STa required for these studies
was established in initial studies using various concentrations; the
final dose that was used was one that abolished net fluid absorp-
tion from the intestine.
Analyses
Naþ, Cl, Kþ, and HCO3
 in perfusate and effluent samples
were measured using ion-sensitive electrodes (Beckman).
[14C]-Polyethylene glycol was measured by liquid scintillation
spectrometry using an LKB 1210 Rackbeta counter.
Solutions
Table 1 lists the composition of the several ORS that were
studied. Polyethylene glycol-4000, consisting of 3 g/L
unlabeled PEG-4000 (catalog no. 81240, Fluka) and 1.2mCi/
L [14C]-PEG-4000 (CFA 508, Amersham Biosciences), was
added to all solutions as a nonabsorbable marker.
Solutions with different osmolalities were used in these
experiments. As detailed in Table 1, osmolality of the basic
ORS was either 311 mOsm/kg H2O (standard WHO glucose-
ORS) or 245 mOsm/kg (reduced osmolarity WHO-ORS). High
amylose maize starch (Hi-Maize) used in these studies and
referred to as RS because it provided amylase-resistant starch.
RS, when added to ORS, did not increase measured osmolarity;
in contrast, because RS replaced glucose in ORS, there was a
drop in osmolarity. To provide appropriate controls for the
further reduction of osmolarity induced by adding RS to
ORS in place of glucose, digestible starch (DS) or RF was
included in additional test solutions to provide solutions of© 2006 by Lippincott Williams & Wilkins.Unauth
TABLE 1. Composition of the experimental oral rehy
G-ORS RS-ORS DS-ORS
Naþ 90 90 90
Cl 80 80 80
Kþ 20 20 20
Citrate 10 10 10
Glucose 111 – –
Resistant starch – 50 g/L –
Digestible starch 50 g/L
Rice flour
Osmolarity 311 200 200
Concentrations are expressed as mmol/L except where shown as g/L. G-ORS
90 mmol/L sodium that was until recently recommended as the universal ORS b
resistant, the other 70% being digestible; DS, digestible starch, expected to und
that is currently recommended by the WHO; RS-RO-ORS, similar to RO-ORS
ORS, rice flour suspended in reduced osmolar ORS instead of glucose.
J Pediatr Gastroenterol Nutr, Vol. 43, No. 5, November 2006similar osmolarity as RS-containing ORS. In RS, 30% of the
starch was amylase resistant, the other 70% being digestible.
The digestible component of the starch was expected to provide
glucose in the small intestine by luminal hydrolysis, and
glucose was therefore excluded from these solutions. In their
composition, they mimic currently used cereal-based ORS. RO
refers to reduced osmolarity ORS that is currently recom-
mended by the WHO. RF refers to rice flour suspended in
reduced osmolar ORS instead of glucose. RS-RO-ORS was
similar to RO-ORS in electrolyte composition but contained RS
in place of glucose and was therefore of lower osmolarity.
Calculations
Net absorption or secretion of water across the gut epi-
thelium was calculated from changes in the concentration
of PEG.
Net water transport (mL/(min/cm)
¼ Vi-½ViðPEGiÞ=ðPEGoÞ=length of gut ðcmÞ  1000
Net electrolyte transport (nmol/(min/cm)
¼ ½EiVi-½EoViðPEGiÞ=ðPEGoÞ=length of gut ðcmÞ 1000
where Vi, PEGi and Ei are volume (in milliliters), PEG
concentration (in milligrams/milliliters) and ion concentration
(in millimoles per liter) of infusate, and PEGo and Eo are PEG
and ion concentrations of effluent fluid.
The mean PEG and electrolyte concentrations of 2 consecu-
tive 15-minute effluent samples after attaining steady state were
used to calculate transport using standard formulas. Steady-
state conditions were ensured in all of the experiments by
ensuring that PEG recovery during the test period equaled
the PEG input during that time period.
Statistics
All of the values were expressed as mean (SEM). Differ-
ences between study groups in water and ion movement were
examined statistically using Kruskal-Wallis analysis of varianceorized reproduction of this article is prohibited.
dration solutions tested in this perfusion system
RO-ORS RS-RO ORS RF-RO-ORS
75 75 75
65 65 65
20 20 20
10 10 10
75 – –
– 50 g/L –
–
50 g/L
245 170 170
indicates the standard glucose-ORS containing 111 mmol/L glucose and
y the WHO; RS, high-amylose maize starch, 30% of which was amylase
ergo complete digestion in small intestine; RO, reduced osmolarity ORS
in electrolyte composition but contained RS in place of glucose; RF-RO-
Copyrigh
FIG. 2. Effect of CT and G-ORS on net water movement (mean
SEM) across the whole gut. Values above the baseline denote
net absorption, and values below denote net secretion into the
lumen of the gut. Compared with control perfusion with Ringer
solution, CT induced net water secretion (P<0.001 compared
with Control-Ringer). This was reversed to net water absorption in
CT-treated animals perfused with G-ORS (P<0.001 compared
with CT/Ringer).
FIG. 3. Effect of complex carbohydrate on net water absorption
from whole gut treated with CT. G-ORS, RS-ORS and DS-ORS
were used. #P<0.001 compared with CT/Ringer; P<0.001
compared with G-ORS and @P<0.02 compared with RS-ORS.
EVALUATION OF ORAL REHYDRATION SOLUTION 571and differences between pairs of individual means were tested
by the Wilcoxon rank sum test.
RESULTS
Validation of the Whole-Gut Perfusion Model
with CT
The initial experiments were designed to compare the
results of whole-gut perfusion with Ringer and glucose-
ORS (G-ORS) solution in control animals and those
pretreated with CT to determine whether the pattern of
results was similar to that observed in similar studies that
were performed with either the entire small intestine or
segments of small intestine. Net water absorption
[1.12 0.08mL/(min/cm)] was observed in control ani-
mals perfused with Ringer solution (Table 2). As expected,
pretreatment with CT induced net water secretion
[0.16 0.05mL/(min/cm); P< 0.001], which was re-
versed to net water absorption [0.46 0.07mL/(min/
cm)] by perfusion with G-ORS (Fig. 2). Net absorption
of sodium and chloride was noted in control animals
perfused with Ringer solution. As anticipated, pretreat-
ment with CTinduced net secretion of sodium and chloride
as well as of potassium and bicarbonate (Table 2). Per-
fusion with G-ORS in CT-treated animals resulted in
significantly higher net absorption of sodium, chloride
and potassium than in CT-treated animals perfused with
Ringer solution (Table 2).
Effect of Amylase-Resistant Starch on Water and
Electrolyte Absorption in CT-Treated Gut
Substitution of glucose in G-ORS by RS-ORS
resulted in substantially higher net absorption of water
[1.93 0.24mL/(min/cm), P< 0.001] compared with
G-ORS (Fig. 3). Net water absorption from DS-ORS
[1.24 0.11mL/(min/cm)] was significantly higher
than from G-ORS (P< 0.001), but was also signifi-
cantly lower than that from RS-ORS (P< 0.02), indi-
cating that reduced osmolarity and amylase-resistant
starch both played roles in the effect of the addition
of starch to ORS. Effects of the different ORS on
electrolyte transport paralleled their effects on water
transport (Table 3).t © 2006 by Lippincott Williams & Wilkins.Unau
TABLE 2. Effect of CT and G-ORS on wh
Na
nmol/(min/cm)
Cl
nmol/(min/cm
Ringer 172.7 17.6 31.5 12.
CT/Ringer 35.4 5.9# 11.9 5.5
CT/G-ORS 2.1 12.4 29.5 9.6
All values shown are the meanSEM of 8 perfusion studies.
# P< 0.001 and ## P< 0.005 compared with control Ringer.  P< 0.01, @ PEffect of Reduced Osmolarity on Water and
Electrolyte Absorption in CT-Treated Gut
Osmolarity is a critical determinant of fluid absorption
with increased fluid absorption observed during per-
fusion with hypoosmolar solutions and net fluid secretionthorized reproduction of this article is prohibited.
ole gut net absorption of electrolytes
)
K
nmol/(min/cm)
Bicarbonate
nmol/(min/cm)
8 0.66 1.2 46.2 6.9
# 5.07 2.2 13.4 1.6##
 19.1 3.6@ 60.6 6.0
< 0.05 and  P< 0.001compared with CT-Ringer.
J Pediatr Gastroenterol Nutr, Vol. 43, No. 5, November 2006
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TABLE 3. Effect of substituting RS and DS for glucose in G-ORS in CT-treated whole gut perfusions
Na
nmol/(min/cm)
Cl
nmol/(min/cm)
K
nmol/(min/cm)
Bicarbonate
nmol/(min/cm)
G-ORS 2.1 12.4 29.5 9.7 19.1 3.6 60.6 6.0
RS-ORS 106.3 29.4 109.6 16.8 22.6 3.4 40.1 7.9
DS-ORS 23.0 9.4# 68.3 9.8 21.3 5.4 43.3 4.8
Values shown are meanSEM of 8 experiments.
 P< 0.001 and  P< 0.05 compared with G-ORS. # P< 0.02 and @ P< 0.02 compared with RS-ORS.
FIG. 4. Effect of reduced osmolarity and complex carbohydrate
on net water absorption from whole gut treated with CT. RO-ORS,
RS-RO-ORS and RF-RO-ORS were used. #P<0.001 compared
with CT/Ringer. P<0.001 compared with RO-ORS. @P<0.05
compared with RS-RO-ORS.
572 SUBRAMANYA ET AL.with hyperosmolar solutions. In the present experiments,
reducing the osmolarity to 245 mOsm/kg significantly
increased net water absorption compared to G-ORS
(P< 0.001) (Fig. 4); these results are identical to prior
experiments that only studied the effect of hypoosmo-
larity on water absorption in the small intestine. The
substitution of glucose in reduced osmolarity ORS by RS
(RS-RO-ORS) significantly increased net water absorp-
tion from CT-treated intestine compared with RO-ORS
(P< 0.001) (Fig. 4). Because this substitution reduced
osmolarity of the ORS further, an additional control was
studied (ie, substitution of glucose by RF). The latter
solution (RF-RO-ORS) was of the same osmolarity as RS-
RO-ORS, but did not contain amylase-resistant starch. Net© 2006 by Lippincott Williams & Wilkins.Unauth
TABLE 4. Effect of substituting RS and RF for glucos
Na
nmol/(min/cm)
Cl
nmol/(min/c
RO-ORS 62.4 8.1 32.7 6.0
RS-RO-ORS 8.5 6.5 66.9 3.5
RF-RO-ORS 34.8 9.1,@ 59.7 8.5
Values shown are meanSEM of 8 experiments.
 P< 0.02,  P< 0.002 and $ P< 0.05 compared with RO-ORS. @ P< 0.05
J Pediatr Gastroenterol Nutr, Vol. 43, No. 5, November 2006water absorption from the RF-RO-ORS was significantly
higher than from RO-ORS (P< 0.001), but was signifi-
cantly lower than that observed with RS-RO-ORS
(P< 0.02) (Fig. 4). Net electrolyte absorption during
perfusion with different solutions is shown in Table 4.
Of note, net sodium secretion was observed during per-
fusion of RO-ORS, which has a lower sodium concen-
tration than standard G-ORS. Induction of hyponatremia
during rehydration therapy is a clinical concern when
using reduced osmolarity ORS in severe diarrhea. Substi-
tution of glucose in RO-ORS by RS or RF significantly
increased net sodium absorption compared with RO-ORS
(P< 0.02 and 0.002, respectively). Net sodium absorption
from RF-RO-ORS was significantly higher than from
RS-RO-ORS (P< 0.05).
ORS Evaluation in STa-Treated Whole Gut
Additional experiments were designed to determine
the importance of both RS and RO in fluid movement in a
model in which increased mucosal cyclic guanosine
monophosphate and not cAMP was responsible for the
changes in intestinal function. As a result, parallel studies
were performed in which fluid secretion was induced by
STa. Perfusion of the intestine with Ringer solution in the
presence of STa induced net fluid secretion (Fig. 5).
Perfusion with G-ORS significantly increased net fluid
absorption in the presence of STa (P< 0.001) (Fig. 5).
Experiments were also performed with RS and reduced-
osmolarity ORS to determine whether these 2 modifi-
cations also enhanced fluid absorption in the presence of
STa, as was observed with CT. Net fluid absorption with
RO-ORS was increased compared with that observed
with G-ORS (P< 0.005) (Fig. 5). When the entireorized reproduction of this article is prohibited.
e in RO-ORS in CT-treated whole gut perfusions
m)
K
nmol/(min/cm)
Bicarbonate
nmol/(min/cm)
4.3 3.0 57.5 5.6
 27.2 5.6 49.6 5.1
$ 15.3 6.3 26.4 5.5,@
compared with RS-RO-ORS.
Copyrigh
FIG. 5. Effect of STa on net water absorption from the whole gut.
G-ORS, RO-ORS, and RS-RO-ORS were used. Ringer solution is
shown for comparison. P<0.005 compared with G-ORS.
@P<0.05 compared with RO-ORS.
EVALUATION OF ORAL REHYDRATION SOLUTION 573intestine was perfused with STa with a solution that both
contained RS and was hypoosmolar, net fluid absorption
was significantly increased compared with that observed
with G-ORS and RO-ORS (P< 0.001). Net secretion of
sodium, chloride and potassium observed in STa per-
fusions with Ringer solution were converted to net
absorption in G-ORS perfusions (Table 5, P< 0.01),
whereas net secretion of bicarbonate was increased in
the presence of G-ORS. No statistically significant differ-
ences in ion absorption were noted between G-ORS,
RO-ORS and RS-RO-ORS groups.
DISCUSSION
This study had 2 objectives: to establish and validate an
experimental method to determine fluid and electrolyte
movement simultaneously in both small and large
intestine, and to use this method to study different
formulations of ORS that may be primarily absorbed
in both small and large intestine. Traditional ORS
formulations have been considered to stimulate fluid
absorption exclusively in the small intestine as
glucose-stimulated sodium absorption is not present in
the colon (1,2). Modifications of ORS including glucose
polymers, amino acids and reduced osmolarity also
enhance small intestinal and not colonic fluid absorption.t © 2006 by Lippincott Williams & Wilkins.Unau
TABLE 5. Net electrolyte absorption from
Na
nmol/(min/cm)
Cl
nmol/(min/c
Ringer 24.1 37.9 34.4 16.
G-ORS 13.8 12.0 49.7 11.
RO-ORS 5.6 12.6ns 50.5 14.
RS-RO-ORS 16.5 13.6ns 72.0 14.
P< 0.01 compared with Ringer solution. ns indicates nonsignificant differenAs a result, prior studies with isolated segments of
proximal or distal or the entire small intestine were
appropriate to evaluate the different ORS formulations
because these are absorbed solely in the small intestine.
The recent development of a modified ORS containing
starch that is relatively resistant to amylase digestion (RS)
is based on the concept that RS is delivered to the colon,
where it exerts physiological effects. Administration of
RS to adults with cholera and to children with non-cholera
diarrhea resulted in reduced fecal output and quicker
recovery from diarrhea (12,20). Because the effectiveness
of RS-ORS is based on enhanced colonic fluid absorption,
an experimental model to study different ORS that
included RS would require one that included a colonic
segment. We are not aware of prior use of perfusion of
small and large intestine in continuity. Figure 1 demon-
strates that steady-state conditions were established
within 60 minutes of the initiation of perfusion of the
entire small and large intestine (exclusive of the
cecum) and persisted up to 300 minutes. The present
experiments were performed using data collected during a
30-minute period following the initiation of steady-
state conditions.
Consistent with many prior observations in small
intestinal segments, whole gut perfusion with CT induced
electrolyte changes mimicking that seen in cholera. The
stimulation of fluid secretion induced by CT was con-
siderably greater than that by STa. The validity of this
model of perfusion of the whole intestine was confirmed
by the ability of G-ORS to stimulate fluid absorption
induced by both CT and STa (Figs. 2 and 5). Recent
studies have demonstrated the efficacy of reduced osmo-
larity RO-ORS in the treatment of several diarrheal
disorders in both children and adults (14–16,21). As a
result, RO-ORS has been established as the preferred
ORS formulation by the WHO. These present exper-
iments demonstrated that RO-ORS enhanced fluid
absorption in the presence of both CT and STa compared
with G-ORS (Figs. 4 and 5), observations that are con-
sistent with both clinical studies and experiments with
isolated segments of small intestine (13).
A critical issue was to determine whether the combi-
nation of reduced osmolarity and resistant starch would
result in a truly ‘‘super-ORS.’’ Before performing clinical
trials, it would be important to provide evidence in anthorized reproduction of this article is prohibited.
whole gut in STa-perfused animals
m)
K
nmol/(min/cm)
Bicarbonate
nmol/(min/cm)
2 9.3 4.3 14.2 12.3
8 28.7 4.5 47.5 4.4
2ns 31.4 7.6ns 46.5 6.2ns
8ns 33.7 6.6ns 38.6 6.5ns
ces between compared groups.
J Pediatr Gastroenterol Nutr, Vol. 43, No. 5, November 2006
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574 SUBRAMANYA ET AL.experimental system about whether the combined use of
RO and RS was better than RO or RS alone. The
present results provide such evidence that the combi-
nation of RS and RO in a single solution designated as
RS-RO-ORS resulted in an enhanced level of fluid
absorption in the presence of both CT and STa. This
observation is consistent with the physiological import-
ance of the colonic reserve capacity to absorb fluid as a
critical determinant of the severity of diarrhea and fecal
fluid losses (22,23) and the demonstration that colonic
absorption is impaired in cholera and other diarrheal
disorders (8,24).
The reduced-osmolarity ORS now recommended by
the WHO is especially useful in diarrhea in children. A
meta-analysis of 15 randomized trials of reduced osmo-
larity ORS in children revealed a small (21%) but sig-
nificant decrease in stool output compared with standard
G-ORS (16). In cholera, the use of reduced osmolarity
solution was associated with hyponatremia in some
subjects (19,21), presumably related to its lower sodium
concentration. In the current perfusion studies, reduced
osmolarity ORS was associated with significantly
increased water absorption from the CT-treated gut
compared with the standard G-ORS, but net sodium
secretion was observed. Substituting RS for glucose in
low-sodium reduced-osmolarity ORS (RS-RO-ORS) sig-
nificantly increased net sodium absorption, suggesting
that RS could provide an advantage in patients with
cholera, resulting in less hyponatremia compared with
reduced-osmolarity ORS. Depleted body potassium and
hypokalemia is another problem that occurs in malnour-
ished children with diarrhea; ReSoMal is an oral
hydration solution that specifically corrects this (7).
The finding in the present study that net potassium
absorption was significantly reduced in CT perfusions
with RO-ORS but was significantly augmented by RS-
RO-ORS suggests that there would be an advantage in
using RS-RO-ORS in malnourished children with
cholera.
The RS used in these studies was actually a mixture of
amylase-resistant starch and digestible starch. The
addition of RS to ORS confers 2 advantages. The diges-
tible component is rapidly hydrolyzed in the small
intestine to glucose leading to stimulation of sodium-
glucose cotransport, without the osmotic penalty of glu-
cose. The amylase-resistant component is expected to
enter the colon and provide additional effects on absorp-
tion. RS-ORS was of substantially lower osmolarity
(200 mOsm/kg) than standard G-ORS (311 m/Osm/kg)
because the glucose was replaced by starch that was not
osmotically active. As an additional control, we studied the
effect of adding (completely amylase-sensitive) digestible
starch to ORS (DS-ORS, osmolarity 200 mOsm/kg) in
the place of RS. This led to a solution of similar osmolarity
to RS-ORS, which provided glucose to stimulate sodium
absorption in the CT-induced secreting small intestine. The© 2006 by Lippincott Williams & Wilkins.Unauth
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absorption to a significantly greater extent than digestible
starch indicates that the effect of the starch was not solely
caused by the reduced osmolarity of RS-ORS but that there
was a colonic component that provided a superior effect.
Rice flour also had an effect on net water and sodium
absorption compared with RO-ORS; compared with
resistant starch, net water absorption was lower but net
sodium absorption higher and net bicarbonate secretion
lower with RF (Table 4). It is possible that RF has an effect
on Na-HCO3 secretion at some level of the gut. Rice
flour contains both digestible and amylase-resistant
starch and may provide some of the effect of amylase-
resistant starch.
It seems clear that malabsorbed carbohydrate can be
useful in the treatment of acute diarrhea (25); however,
not all malabsorbed carbohydrates may be equally useful
in management of acute diarrhea (26). There have been
variable results with the addition of malabsorbed carbo-
hydrates such as partially hydrolyzed guar gum and a
mixture of nondigestible carbohydrates in treating chil-
dren with non-cholera diarrhea. The former hastened
recovery from diarrhea (27), whereas the latter was
not effective (28). The differences between these clinical
trials may result from the nature of the carbohydrate
chosen (ie, whether it increased osmolarity) as well as the
nature of the diarrhea. Thus, rice-based ORS is generally
not more effective than G-ORS in children with non-
cholera diarrhea. We speculate that the amylase-resistant
component of RS stimulates SCFA-dependent sodium
absorption from the colon, although this was not directly
examined in the present study. Administration of RS to
rats results in its being fermented in the colon to SCFA by
luminal bacteria (29). Short chain fatty acid–stimulated
sodium absorption in the colon is not inhibited by cAMP,
despite its requirement for Na-H exchange (9,30). Short
chain fatty acids increase sodium absorption via the Na-H
exchange isoform 2 (NHE2), which is expressed on
the apical membrane of colonic epithelial cells and is
upregulated by cAMP (31). In addition, SCFAs inhibit
active chloride secretion in the colon (30,32), which may
explain the significantly increased chloride absorption
from the starch-containing ORSs compared with the
glucose-containing ORSs (Tables 3 and 5). The perfusion
system described here may wash out fecal bacteria to an
extent that it prevents colonic fermentation. This is also a
situation that may occur in severe acute diarrhea. Alterna-
tive effects of malabsorbed carbohydrate on colonic fluid
absorption, including reduced nitric oxide levels in colon
as has been suggested for gum arabic (33), cannot be
excluded. In the present perfusion studies of the whole
gut, increased net water absorption from RS-RO-ORS
suggests that it may reduce fecal fluid loss in acute
diarrhea compared with RO-ORS. This solution should
be tested in clinical trials in children and adults
with diarrhea with the expectation that it may provideorized reproduction of this article is prohibited.
Copyrigh
EVALUATION OF ORAL REHYDRATION SOLUTION 575clinical improvement compared with either RS-ORS or
RO-ORS alone.
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